Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase I study of aplidine as a three-hour infusion in solid tumor patients

June 3, 2002

Survival benefit for long-term atrasentan in HRPCa

June 3, 2002

Antitumor xanthone compounds obtained from Streptomyces

June 3, 2002

New prenyltransferase inhibitors in early development at Merck

June 3, 2002

MLN-518 enters phase I in AML

May 31, 2002

Single-dose palonosetron provides prolonged relief from CINV

May 31, 2002

LymphoRad targets B-cells and B-cell tumors and exerts antitumor activity in preclinical studies

May 31, 2002

Phase I results support further development of ABX-EGF for cancer

May 31, 2002

Potent inhibitor of Jak family protein tyrosine kinases discovered at Merck

May 31, 2002

Early clinical data for DRF-1042 presented at ASCO

May 31, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...